Current Funding Opportunities

Through our research program, Komen awards grants to support cutting-edge breast cancer research that will provide the greatest benefit to patients. We’re focused on conquering metastatic and aggressive breast cancers, advancing personalized breast care and eliminating breast cancer disparities and inequities. Our goal is to improve breast health care and outcomes for everyone and save lives.

Each year, we release Request for Applications (RFA) to communicate which grant mechanisms and scientific focus areas are available for funding. The types of mechanisms and the scientific focus areas may vary from year to year. Our latest research funding opportunities are available below!

Komen Application and Review Process

Susan G. Komen® utilizes a multi-step approach to grant application and review that first requires limited submission of a Letter of Intent (LOI) and upon invitation only, submission of an Application.  Applicants/Primary Investigators (PIs) will be notified of LOI review decisions via email. Applicants/PIs invited to submit an Application will then be granted access to the Application site in proposalCENTRAL.  

Applicants will be notified of intent to fund on or around April 15, 2027. All institutions must agree to adhere to Komen’s Policies and Procedures for Research and Training Grants. A copy of the latest version of these awards is found with the other documents for the LOI or Application in proposalCENTRAL. 

Click on the topic below to learn more about current funding opportunities.

Susan G. Komen Career Catalyst Research (CCR) Grants Key Dates:

Letter of Intent (LOI) Announcement: May 28, 2026
Institution Opt-in Deadline: June 10, 2026
Letter of Intent Due: July 29, 2026, by 1 pm, ET
Letter of Intent Decision: August 17, 2026
Application Due: October 5, 2026, by 1 pm, ET

About the Grant: Susan G. Komen Career Catalyst Research (CCR) Grants foster promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of “protected time” for research career development under the guidance of a Mentor Committee. We seek to support those who will emerge as the next key leaders in the fight against breast cancer.

CCR Grant Terms: Applicant/Primary Investigator (PI) may request funding of up to $150,000 per year (combined direct and indirect costs) for up to three years ($450,000).

CCR Limited Submission Nomination Process: Institutions must respond to missiongrantsadmin@komen.org by June 10, 2026, to indicate that they are opting in to the institutional nomination process. This is a limited submission opportunity: each institution may submit up to two nominees to apply for this funding. Applicant/PI cannot self-nominate. The Institution’s Office of Sponsored Programs, Grants Office, or equivalent must select the nominees to apply for this funding.

Prior to the LOI submission deadline (July 29, 2026), institutions that have opted in must provide Komen with the names and email addresses of the two applicants (based on eligibility requirements) being nominated to apply for funding. Institutions will receive a link that their nominees may use to submit the required documents for LOI submission.

CCR Eligibility: Applicant/PI must currently hold a full-time faculty appointment or have a formal offer letter from the Institution that confirms their position and start date by the Application due date (October 5, 2026). Applicants/PIs must not have held any faculty appointment, including non-tenure and tenure track appointments combined, for more than a total of 6 years by the Application due date (October 5, 2026).

CCR Research Focus: Research projects must be hypothesis-driven, breast cancer-focused studies. They may be considered basic, translational, clinical and/or population science in nature and should align with Komen’s research priorities and mission to save lives from breast cancer.

Download the current Career Catalyst Research LOI Announcement (PDF) for more details